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ABSTRACT 
Objective: The present study aims to develop a simple, sensitive, specific, and validated colorimetric method for the quantitative estimation of 
Salbutamol Sulphate in bulk and pharmaceutical dosage form. 
Method: A simple colorimetric method for the determination of Salbutamol Sulphate in pure as well as in its dosage form has been developed. The 
method is based on formation of a blue coloured chromogen by the interaction of Salbutamol Sulphate with Folin–Ciocalteu reagent under basic 
condition and the maximum absorbance of the developed chromogen was found. The developed method is validated in terms of Linearity, Accuracy, 
Precision, Limit of Detection, Limit of Quantitation, as per ICH Guidelines. 
Results: The λmax
Conclusion: The proposed method makes use of simple reagent, which an ordinary analytical laboratory can afford. The method was found to be 
simple, precise, economic and less time consuming. The method has been statistically evaluated and results obtained are accurate, precise and 
insensitive and free from the interferences of other additives present in the formulation.  
 was found to be 723nm for assay. Linearity was found in the concentration range of 10-50 µg/ml respectively with a correlation 
coefficient of 0.9979. The regression equation was found as y=bx+a: 0.0199x+0.0208. 





Spectrometric methods are a large group of analytical methods that 
are based on atomic and molecular spectroscopy[1]. Colorimetric 
assays generally consists of adding a reagent to the assay 
preparation or to the substance being tested, to produce a color that 
is compared with that of a standard preparation that has been 
prepared simultaneously and contains approximate quantity of the 
reference standard[2]. In general, in analysis the first step is to 
determine the nature of the sample that is complete qualitative 
information and then further proceed for quantitative information 
by accuracy, LOD, LOQ etc [3]. Method validation is the process to 
confirm that the analytical procedure employed for a specific test is 
suitable for its intended use [4]. The parameters for method 
validation have been defined in different working groups of national 
and international committees and are described in the literature [5]. 
Salbutamol Sulphate is a beta-2-adrenoceptor agonist and 
bronchodilator. Chemically Salbutamol Sulphate is Bis[(1RS)-2-
[(1,1-dimethylethyl)amino]-1-[4-hydroxy-3-
(hydroxymethyl)phenyl]ethanol] sulphate (fig. 1). Salbutamol is a 
beta-(2)-adrenergic agonist and thus it stimulates beta-(2)-
adrenergic receptors. Binding of Salbutamol to beta-(2)-receptors in 
the lungs results in relaxation of bronchial smooth muscles. It is 
believed that Salbutamol increases cAMP production by activating 
adenylate cyclase, and the actions of Salbutamol are mediated by 
cAMP. Increased intracellular cyclic AMP increases the activity of 
cAMP-dependent protein kinase A, which inhibits the 
phosphorylation of myosin and lowers intracellular calcium 
concentrations. A lowered intracellular calcium concentration leads 
to a smooth muscle relaxation and bronchodilation. In addition to 
bronchodilation, Salbutamol inhibits the release of 
bronchoconstricting agents from mast cells, inhibits microvascular 
leakage, and enhances mucociliary clearance. It is freely soluble in 
water, practically insoluble or very slightly soluble in ethanol (96 
per cent) and in methylene chloride[[6,7,8]]. The literature survey 
reveals that few methods are reported for the determination of 
Salbutamol Sulphate such as Thin layer chromatography, RP 
isocratic HPLC, UHPLC etc[9,[10,11,12],[13,14]]
MATERIALS AND METHODS 
. Validation 
characteristics evaluated are Specificity, Accuracy, Precision, Limit 
of detection, Limit of quantitation, Linearity, Range, Ruggedness and 
Robustness. The method is based on formation of a blue coloured 
chromogen by the interaction of Salbutamol Sulphate with Folin–
Ciocalteu reagent under basic condition. 
Shimadzu UV spectrophotometer 1700 and JascoV-630 
spectrophotometer with 1 cm matched quartz cells was used for all 
spectral and absorbance measurements. Pure drug was procured 
from Yarrow Chem Products Ltd, Mumbai as a gift sample. Basic 
apparatus like calibrated volumetric flasks, pipette, beakers and 
graduated pipettes were used. 
Experimental 
Preparation of stock solutions 
100 mg standard Salbutamol Sulphate was weighed and transferred 
to a 100 ml volumetric flask and dissolved in distilled water. The 
flask was shaken and volume was made up to the mark with distilled 
water to get a concentration of 1000 µg/ml (Stock solution A). From 
this stock solution A, 10 ml solution was pipetted out and placed 
into 100 ml volumetric flask. The volume was made up to mark with 
distilled water to get a concentration of 100µg/ml (Stock solution B). 
Preparation of reagents and chemicals 
a) Preparation of 1N NaOH 
4 gm of NaOH was dissolved in 100 ml of distilled water. 
b) Preparation of 2N FCR 
50 ml of standard phenol reagent was taken and diluted to 100 ml 
with distilled water. 
Determination of [λmax
Selection of analytical wavelength  
]  
To a 10 ml volumetric flask, 1 ml of drug solution (100μg/ml) from 
Stock solution B was added. To the flask 0.8 ml of 2N FCR solution 
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and 6 ml of distilled water was added. The volumetric flask was 
shaken well for at least 5 min followed by addition of 1.5 ml of 1N 
NaOH solution. The volume was made up to the mark and stored for 
15 min in the dark. The absorbance reading was taken against the 
blank. The solution was scanned in UV spectrophotometer between 
800-400 nm. Absorption spectra obtained showed the absorption 
maxima [λmax
Preparation of Standard curve 
] 723 nm, which was selected as wavelength for 
analytical measurements. Absorption maxima obtained is given in 
fig. 2 
A series of concentration of 10-50μg/ml were prepared of drug 
solution from Stock Solution (B) in 10 ml volumetric flasks by 
adding 1 ml, 2 ml, 3 ml, 4 ml and 5 ml respectively. To each 
appropriately labeled flask 0.8 ml of 2N FCR solution and 6 ml of 
distilled water was added. The volumetric flasks were shaken well 
for at least 5 min followed by addition of 1.5 ml of 1N NaOH solution. 
The volume was made up to the mark and stored for 15 min in the 
dark. The absorbance was measured at 723 nm against the reagent 
blank. The result was recorded in table 1 and graph is given in fig. 3. 
Method validation 
1) Linearity 
Linearity was determined over the range of 10–50 μg/ml for 
Salbutamol Sulphate. Accurately measured Stock solution B of 
Salbutamol Sulphate (1, 2, 3, 4, and 5 ml) was transferred to one set 
of a series of 10 ml volumetric flasks. To each appropriately labeled 
flask 0.8 ml of 2N FCR solution and 6 ml of distilled water was 
added. The volumetric flasks were shaken well for at least 5 min 
followed by addition of 1.5 ml of 1N NaOH solution. The volume was 
made up to the mark and stored for 15 min in the dark. A spectrum 
was recorded by placing drug solutions and diluent in sample and 
reference cells respectively. The absorbance was measured at 723 
nm (Peak maxima) and was plotted vs. concentration to give 
calibration curve, and regression equation and correlation 
coefficient was calculated and presented in table 2 and fig. 3. The 
calibration curve of amplitude of absorbance against concentration 
of the drug showed linearity. 
2) Sensitivity 
The sensitivity of the proposed method for measurement of 
Salbutamol Sulphate was estimated in terms of limit of detection 
[LOD] and limit of quantification [LOQ]. The LOD and LOQ were 
calculated by using the slope and SD of response. The mean slope 
value and SD of response were obtained after plotting six calibration 
curves. The LOD and LOQ obtained are reported in table 2. 
3) Precision 
The precision of the method was established by system precision 
and method precision. System Precision was subjected to intraday 
and inter-day variation studies.  
a) System Precision 
Intraday precision was determined by using three different levels of 
drug concentrations (10, 20, 30 µg/ml) prepared from Stock 
solution B and each level was analyzed three times in a day. Same 
procedure was followed for three different days to study the Inter-
day precision. Data obtained are given in the table 2. 
b) Method Precision 
Method precision was determined by using sample solution of drug 
concentrations (10, 20, 30, 40 and 50µg/ml) and it was analyzed six 
times in a day by the same analyst. Data obtained are given in the 
table 2. 
4) Accuracy 
Recovery studies by the standard addition method were performed 
to study the accuracy of the proposed method. Preanalysed samples 
of Salbutamol Sulphate (10 µg/ml) were spiked with 80, 100 and 
120 % extra Salbutamol Sulphate standard and the mixture were 
analyzed with the proposed method. Accuracy was assessed as the 
% Recovery at each concentration level. Data obtained from 
accuracy study are given in table 2. 
5) Ruggedness 
To establish ruggedness of the proposed method, assays for two 
different concentrations of Salbutamol Sulphate tablets were 
performed by two different analysts. The results of assays are 
represented as % Recovery with SD and % RSD showing the 
ruggedness of the proposed method are illustrated in table 2. 
6) Robustness 
The absorbance readings of 10µg/ml were measured at different 
laboratory using different spectrophotometer by another analyst 
and the %RSD values obtained to verify their robustness. Data 
obtained are given in the table 2. 
7) Specificity 
Refers to the extent to which the method can be used to determine 
particular analytes in mixtures or matrices without interferences 
from other components of similar behavior. The data obtained are 
given in the table 3. 
Stability of colour 
A 10 µg/ml concentration of Salbutamol Sulphate was prepared as a 
working solution and the absorbance was recorded after a period of 
every 5 minutes in a time span of 90 minutes. The data obtained are 
shown in the table 4 and fig. 4 
Analysis of marketed formulation 
Preparation of sample solution:  
A tablet marketed formulation, Asthalin-2 (Cipla Ltd.) was taken 
for analysis. Tablet powder equivalent to 100 mg was weighed 
accurately and transferred into 100 ml volumetric, to this 70 ml 
of distilled water was added and the volumetric flask was 
vigorously shaken for about 20 minutes. Finally the volume was 
made up to the mark with distilled water to get 1000μg/ml 
concentration (Stock Solution A). The above solution was 
carefully filtered through Whatman filter paper (No. 41). From 
this solution 10 ml was pipetted into a 100 ml volumetric flask 
and made up to the mark with distilled water to obtain 100 
μg/ml, (Stock Solution B) 
Recovery experiments 
From Stock solution B, 2 ml was pipetted out into a 10 ml volumetric 
flask. Then 0.8 ml of 2N FCR solution and 6 ml of distilled water was 
added. The volumetric flask was shaken well for at least 5 min 
followed by addition of 1.5 ml of 1N NaOH solution. The volume was 
made up to the mark and stored for 15 min in the dark. The 
absorbance was read at 723 nm against the reagent blank. The result 
was recorded in table 5. 
 
Fig. 1: Salbutamol Sulphate 
 
 
Fig. 2: λmax of coloured species of Salbutamol Sulphate 
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Fig. 3: Standard curve for Salbutamol Sulphate at 723 nm 
 
 
Fig. 4: Stability of colour 
Table 1: Standard curve for salbutamol sulphate 
S. 
No. 






Absorbance at 723 
nm mean±S. D. 
(n=6) 
1 1 ml 10 0.224±0.002428 
2 2 ml 20 0.437±0.003983 
3 3 ml 30 0.634±0.003899 
4 4 ml 40 0.825±0.004412 
5 5 ml 50 0.996±0.001871 
 
Table 2: Statistical data for Salbutamol Sulphate by colorimetric 
method 







Slope (b) 0.0199 


























Inter day 0.32-0.44 
Robustness 0.40-0.62 
Ruggedness:   
Analyst I  99.88±0.5392-100.40±0.6557 
Analyst II 99.43±0.3055-100.05±0.3041 
Accuracy 
(recovery, n=3)  
% Mean recovery 
1) At Level-1 (80%)= 99.70±0.4518 2) At 
Level 2(100%)= 99.50±0.2316 
3) At Level-3(120%)= 99.84±0.3772 
*y = bx+a where x is the concentration of Salbutamol Sulphate in 
μg/ml and y is the absorbance at the respective wavelength. 
 
Table 3: Specificity 
Study Salbutamol Sulphate 
Specificity Specific 
Table 4: Stability of colour 
S. 
No. 
Volume of drug solution in 10 





at 723 nm 
1 1 ml 0 0.253 
2 1 ml 5 0.254 
3 1 ml 10 0.256 
4 1 ml 15 0.260 
5 1 ml 20 0.253 
6 1 ml 25 0.253 
7 1 ml 30 0.252 
8 1 ml 35 0.252 
9 1 ml 40 0.252 
10 1 ml 45 0.251 
11 1 ml 50 0.252 
12 1 ml 55 0.252 
13 1 ml 60 0.251 
14 1 ml 65 0.251 
15 1 ml 70 0.251 
16 1 ml 75 0.251 
17 1 ml 80 0.250 
18 1 ml 85 0.250 
19 1 ml 90 0.250 
 












Tablet 20 μg/ml 19.68 μg/ml 98.40% 
 
RESULTS AND DISCUSSION 
Proposed reaction  
Folin–Ciocalteu reagent which is a mixture of tungstates and 
molybdates works on the mechanism of oxidation–reduction 
reaction. The method is based on the reduction of the mixture 
heteropolyphosphotungsates–molybdates by the phenolic group of 
Salbutamol Sulphate which results in the formation of blue coloured 
chromogen. The phenolic group reacts with Folin–Ciocalteu reagent 
only under basic conditions adjusted by Sodium Hydroxide solution. 
Salbutamol Sulphate brings about a reduction of 1or 2 or 3 oxygen 
atoms from tungstate and/or molybdate in Folin–Ciocalteu reagent 
there by producing one or more of the possible reduced species 
which have a characteristic intense blue color. 
The mixed acids present in Folin Ciocalteau reagent involve the 
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Optical conditions, optical characteristics and statistical data of 
the regression equation in colorimetric method 
The optical characteristics such as Beer’s law limits, Limit of detection, 
Limit of quantitation, regression characteristics like slope (b), intercept 
(a), and correlation coefficient (R2
Declared None 
) using the method of least squares 
were calculated and the results was presented in table 2. The linearity 
was found in the concentration range 10-50 μg/ml. The method was 
validated for accuracy, precision, ruggedness and robustness. Values for 
both system precision and method precision in terms of % RSD were 
found to be less than 2, indicating that the method was accurate and 
precise. Ruggedness was studied with the help of two analysts. 
Robustness of the method was studied in two different laboratories 
using two different UV-visible spectrophotometers. The results did not 
show any statistical difference between operators and environmental 
conditions, indicating that method developed was rugged and robust. 
For stability of coloured species of Salbutamol Sulphate, the colour was 
found to be stable for a period of 90 minutes, showing highest 
absorbance at 15 minutes. The method developed was found to be 
simple, sensitive, accurate, precise and economical and can be used in 
the determination of Salbutamol Sulphate from pharmaceutical 
formulations in a routine manner. 
CONCLUSION 
For routine analytical purpose, it is always necessary to establish 
methods capable of analyzing huge number of samples in a short 
time period with due accuracy and precision. Few analytical 
methods appeared in the literature for the determination of 
Salbutamol Sulphate. Proposed method makes use of simple reagent, 
which an ordinary analytical laboratory can afford. The method was 
found to be simple, precise, economic and less time consuming. In 
the present investigation, colorimetric method for the quantitative 
estimation of Salbutamol Sulphate in bulk drug and pharmaceutical 
formulations has been developed. 
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